Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy

Iwan Harries, MBBCh; Kate Liang, MBBCh; Matthew Williams, MBChB; Bostjan Berlot, MD; Giovanni Biglino, PhD; Patrizio Lancellotti, MD, PhD; Juan Carlos Plana, MD; Chiara Bucciarelli-Ducci, MD, PhD

JACC. CardioOncology (Jun 2020)

Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy

Iwan Harries, MBBCh,
Kate Liang, MBBCh,
Matthew Williams, MBChB,
Bostjan Berlot, MD,
Giovanni Biglino, PhD,
Patrizio Lancellotti, MD, PhD,
Juan Carlos Plana, MD,
Chiara Bucciarelli-Ducci, MD, PhD

Affiliations

Iwan Harries, MBBCh: Bristol Heart Institute, Bristol National Institute of Health Research (NIHR) Biomedical Research Centre, University Hospitals Bristol NHS Trust and University of Bristol. Bristol, United Kingdom
Kate Liang, MBBCh: Bristol Heart Institute, Bristol National Institute of Health Research (NIHR) Biomedical Research Centre, University Hospitals Bristol NHS Trust and University of Bristol. Bristol, United Kingdom
Matthew Williams, MBChB: Bristol Heart Institute, Bristol National Institute of Health Research (NIHR) Biomedical Research Centre, University Hospitals Bristol NHS Trust and University of Bristol. Bristol, United Kingdom
Bostjan Berlot, MD: Bristol Heart Institute, Bristol National Institute of Health Research (NIHR) Biomedical Research Centre, University Hospitals Bristol NHS Trust and University of Bristol. Bristol, United Kingdom; Department of Cardiology, University Medical Centre Ljubljana, Slovenia
Giovanni Biglino, PhD: Bristol Heart Institute, Bristol National Institute of Health Research (NIHR) Biomedical Research Centre, University Hospitals Bristol NHS Trust and University of Bristol. Bristol, United Kingdom; National Heart and Lung Institute, Imperial College London, London, United Kingdom
Patrizio Lancellotti, MD, PhD: University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium; Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy
Juan Carlos Plana, MD: Texas Heart Institute at Baylor St. Luke’s Medical Center, Baylor College of Medicine, Houston, Texas, USA
Chiara Bucciarelli-Ducci, MD, PhD: Bristol Heart Institute, Bristol National Institute of Health Research (NIHR) Biomedical Research Centre, University Hospitals Bristol NHS Trust and University of Bristol. Bristol, United Kingdom; Address for correspondence: Dr. Chiara Bucciarelli-Ducci, Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Upper Maudlin Street, Bristol BS2 8HW, United Kingdom.

Journal volume & issue: Vol. 2, no. 2
pp. 270 – 292

Abstract

Read online

This paper aims to empower and inform cardio-oncologists by providing a practical guide to the clinical application of cardiac magnetic resonance (CMR) in the rapidly evolving field of cardio-oncology. Specifically, we describe how CMR can be used to assess the cardiovascular effects of cancer therapy. The CMR literature, relevant societal guidelines, indication-specific imaging protocols, and methods to overcome some of the challenges encountered in performing and accessing CMR are reviewed.

Published in JACC. CardioOncology

ISSN: 2666-0873 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system; Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.journals.elsevier.com/jacc-cardiooncology

About the journal

Abstract

Keywords